ARTICLE | Company News
Allergan, GlaxoSmithKline sales and marketing update
October 10, 2005 7:00 AM UTC
AGN granted GSK development and commercialization rights for Botox in China and Japan. The botulinum toxin is approved to treat uncontrollable blinking, hemifacial spasm and cervical dystonia. AGN wi...